FDA NDC Directory · JSON-LD · Markdown

Terazosin

NDC 50268-765 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameTerazosin Hydrochloride
Labeler / ManufacturerAvPAK
Marketing categoryAbbreviated NDA (generic) · App ANDA075317
Dosage form / routeCAPSULE · ORAL
Active ingredientsTERAZOSIN HYDROCHLORIDE (2 mg/1)
Marketing started20200213
Package count1

External sources

Source: openFDA. Public-domain (CC0).